ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 7, 2007, Pages 691-698

  Fox, Annette ^a   Jeffries, David J ^a   Hill, Philip C ^a   Hammond, Abdulrahman S ^a   Lugos, Moses D ^a   Jackson Sillah, Dolly ^a   Donkor, Simon A ^a   Owiafe, Patrick K ^a   McAdam, Keith P W J ^a   Brookes, Roger H ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

CFP 10; Disease; ELISPOT; ESAT 6; Infection; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; PROTEIN DERIVATIVE; TUBERCULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; SCHOOL CHILD; SENSITIVITY ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34248212174     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.03.001     Document Type: Article

References (33)

1. Arend S.M., Andersen P., van Meijgaarden K.E., Skjot R.L., Subronto Y.W., van Dissel J.T., and Ottenhoff T.H. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181 (2000) 1850-1854
2. Arend S.M., Geluk A., van Meijgaarden K.E., van Dissel J.T., Theisen M., Andersen P., and Ottenhoff T.H. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect. Immun. 68 (2000) 3314-3321
3. Arend S.M., Engelhard A.C., Groot G., de Boer K., Andersen P., Ottenhoff T.H., and van Dissel J.T. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin. Diagn. Lab. Immunol. 8 (2001) 1089-1096
4. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., and Small P.M. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 (1999) 1520-1523
5. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., and Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144 (1998) 3195-3203
6. Black G.F., Weir R.E., Floyd S., Bliss L., Warndorff D.K., Crampin A.C., Ngwira B., Sichali L., Nazareth B., Blackwell J.M., Branson K., Chaguluka S.D., Donovan L., Jarman E., King E., Fine P.E., and Dockrell H.M. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359 (2002) 1393-1401
7. Chapman A.L., Munkanta M., Wilkinson K.A., Pathan A.A., Ewer K., Ayles H., Reece W.H., Mwinga A., Godfrey-Faussett P., and Lalvani A. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16 (2002) 2285-2293
8. Colangeli R., Spencer J.S., Bifani P., Williams A., Lyashchenko K., Keen M.A., Hill P.J., Belisle J., and Gennaro M.L. MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infect. Immun. 68 (2000) 990-993
9. de Jong B.C., Hill P.C., Brookes R.H., Gagneux S., Jeffries D.J., Otu J.K., Donkor S.A., Fox A., McAdam K.P., Small P.M., and Adegbola R.A. Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J. Infect. Dis. 193 (2006) 1279-1286
10. Diel R., Nienhaus A., Lange C., and Schaberg T. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur. Respir. J. 28 (2006) 35-44
11. Dillon D.C., Alderson M.R., Day C.H., Lewinsohn D.M., Coler R., Bement T., Campos-Neto A., Skeiky Y.A., Orme I.M., Roberts A., Steen S., Dalemans W., Badaro R., and Reed S.G. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect. Immun. 67 (1999) 2941-2950
12. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., Meccugni B., Dori I.M., Andreani A., Bergamini B.M., Mussini C., Rumpianesi F., Fabbri L.M., and Richeldi L. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
13. Gordon S.V., Brosch R., Billault A., Garnier T., Eiglmeier K., and Cole S.T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32 (1999) 643-655
14. Harboe M., Oettinger T., Wiker H.G., Rosenkrands I., and Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64 (1996) 16-22
15. Hill P.C., Brookes R.H., Fox A., Fielding K., Jeffries D.J., Jackson-Sillah D., Lugos M.D., Owiafe P.K., Donkor S.A., Hammond A.S., Otu J.K., Corrah T., Adegbola R.A., and McAdam K.P. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin. Infect. Dis. 38 (2004) 966-973
16. Hill P.C., Jackson-Sillah D., Fox A., Franken K.L., Lugos M.D., Jeffries D.J., Donkor S.A., Hammond A.S., Adegbola R.A., Ottenhoff T.H., Klein M.R., and Brookes R.H. ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia. J. Clin. Microbiol. 43 (2005) 2070-2074
17. Huebner R.E., Schein M.F., and Bass Jr. J.B. The tuberculin skin test. Clin. Infect. Dis. 17 (1993) 968-975
18. Jeffries D.J., Donkor S., Brookes R.H., Fox A., and Hill P.C. Design and implementation of relational databases relevant to the diverse needs of a tuberculosis case contact study in the Gambia. Int. J. Tuberc. Lung Dis. 8 (2004) 1095-1099
19. Jeffries D.J., Hill P.C., Fox A., Lugos M., Jackson-Sillah D.J., Adegbola R.A., and Brookes R.H. Identifying ELISPOT and skin test cut-offs for diagnosis of Mycobacterium tuberculosis infection in The Gambia. Int. J. Tuberc. Lung Dis. 10 (2006) 192-198
20. Kang Y.A., Lee H.W., Yoon H.I., Cho B., Han S.K., Shim Y.-S., and Yim J.-J. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293 (2005) 2756-2761
21. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., and McMichael A.J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186 (1997) 859-865
22. Lalvani A., Nagvenkar P., Udwadia Z., Pathan A.A., Wilkinson K.A., Shastri J.S., Ewer K., Hill A.V., Mehta A., and Rodrigues C. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183 (2001) 469-477
23. Lalvani A., Pathan A.A., Durkan H., Wilkinson K.A., Whelan A., Deeks J.J., Reece W.H., Latif M., Pasvol G., and Hill A.V. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357 (2001) 2017-2021
24. Lein A.D., von Reyn C.F., Ravn P., Horsburgh Jr. C.R., Alexander L.N., and Andersen P. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 6 (1999) 606-609
25. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., Shigeto E., Harada N., Mitarai S., Okada M., Suzuki K., Inoue Y., Tsuyuguchi K., Sasaki Y., Mazurek G.H., and Tsuyuguchi I. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170 (2004) 59-64
26. Mustafa A.S., Amoudy H.A., Wiker H.G., Abal A.T., Ravn P., Oftung F., and Andersen P. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand. J. Immunol. 48 (1998) 535-543
27. Simmons C.P., Thwaites G.E., Quyen N.T., Torok E., Hoang D.M., Chau T.T., Mai P.P., Lan N.T., Dung N.H., Quy H.T., Bang N.D., Hien T.T., and Farrar J. Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J. Immunol. 176 (2006) 2007-2014
28. Sorensen A.L., Nagai S., Houen G., Andersen P., and Andersen A.B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63 (1995) 1710-1717
29. Ulrichs T., Anding P., Porcelli S., Kaufmann S.H., and Munk M.E. Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68 (2000) 6073-6076
30. van Pinxteren L.A., Ravn P., Agger E.M., Pollock J., and Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol. 7 (2000) 155-160
31. Vekemans J., Lienhardt C., Sillah J.S., Wheeler J.G., Lahai G.P., Doherty M.T., Corrah T., Andersen P., McAdam K.P., and Marchant A. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect. Immun. 69 (2001) 6554-6557
32. Whalen C.C. Diagnosis of latent tuberculosis infection: measure for measure. JAMA 293 (2005) 2785-2787
33. Wrighton-Smith P., and Zellweger J.P. Direct costs of three models for the screening of latent tuberculosis infection. Eur. Respir. J. 28 (2006) 45-50